AstraZeneca and Eisai urge UK to remain part of EMA

09-01-2018

AstraZeneca and Eisai urge UK to remain part of EMA

enviromantic / iStockphoto.com

UK-headquartered AstraZeneca and Japanese pharmaceutical company Eisai have urged the UK to remain a member of the European Medicines Agency (EMA).


European Medicines Agency, EMA, relocation, health, public health, crisis, Brexit, medicines,

LSIPR